This is an initiative by Medtalks, in association with Mankind Pharma. Through this news bulletin, we aim to bring to you everything that is new in the field of diabetes care from across the world
In this issue we will discuss about Diabetes, Metabolic syndrome and COVID-19 patients.
According to a new study patients hospitalized with COVID-19 who had a combination of high blood pressure, obesity and diabetes were over three times more likely to die from the disease.
The study, published in the journal Diabetes Care, is the first to look at the impact of metabolic syndrome on outcomes for COVID-19 patients.